UK's CHMP Grants Positive Review of MEK Inhibitor Melanoma Drug Mekinist The UK's Committee for Medicinal Products for Human Use (CHMP) recommended that the European Commission grant marketing authorization to GlaxoSmithKline's Mekinist (trametinib).

GoodStart Genetics has appointed Charles Wagner, Jr., to its board of directors. Wagner is CFO and executive VP of finance and administration at Bruker Corporation. Previously, he held similar positions at Progress Software Corporatio and Millipore Corporation.

NEW YORK (GenomeWeb) – Nuclea Biotechnologies today said it has inked an agreement with Clinical Reference Laboratory to validate three of Nuclea's tests.

In the wake of the investigation of Riken stem cell scientist Haruko Obokata, more researchers apologize.

A small study indicates that a mother's diet around the time of conception can influence the epigenome of her child.

Carl Zimmer explores where genes come from in the New York Times.

In Genome Research this week: genome architecture variation in fruit flies, supercentenarian genome, and more.

NEW YORK (GenomeWeb) – Illumina has launched its VeriSeq test for preimplantation genetic screening on the MiSeq platform, the company said this week.

NEW YORK (GenomeWeb) − A group of mostly US-based genomics and clinical sequencing experts has put forward a set of guidelines for determining whether a rare sequence variant is causally linked to a disease.

NEW YORK (GenomeWeb) — OncoDNA, a clinical NGS provider affiliated with the Institute of Pathology and Genetics in Gosselies, Belgium, announced last week that it is providing targeted sequencing of metastatic breast cancer patients for a large international effort called AURORA, led by the Breas

NEW YORK (GenomeWeb) – The University Medical Center Utrecht is offering a range of next-generation sequencing-based tests, including noninvasive prenatal testing on Life Technologies' SOLiD 5500xl Wildfire system, exome sequencing for intellectual disability on the Illumina HiSeq, and targeted g

Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects. Balabanski L, Antov G, Dimova I, Ivanov S, et al. Mol Clin Oncol. 2014 May;2(3):435-439.

Ariosa Diagnostics has elected Kate Falberg to its board of directors and to chair of the audit committee. Falberg most recently served as executive vice president and CFO of Jazz Pharmaceuticals.

The Mayo Clinic has launched CANCP, a 50-gene cancer panel that assesses hotspot mutations using next-generation sequencing with the goal of predicting a patient's response to therapy. The test is available to Mayo patients and providers worldwide through Mayo Medical Laboratories.

NEW YORK (GenomeWeb) – PerkinElmer has decided to close its Signature Genomics cytogenetic testing services business.

NEW YORK (GenomeWeb) – Danaher's Leica Biosystems will use Flagship Biosciences' custom algorithms to develop companion diagnostics on the Aperio ePathology imaging platform, Flagship said today. Financial and other terms of the deal were not disclosed.

NEW YORK (GenomeWeb) – Protea Biosciences Group said today that it has undertaken a collaborative research effort with Memorial Sloan Kettering Cancer Center and the Dana-Farber Cancer Institute with an initial focus on lung cancer.

NEW YORK (GenomeWeb) – Hologic today announced that its subsidiary Tepnel Pharma Services achieved customer service provider status in Life Technologies' Ion Torrent Service Provider program on the Ion Personal Genome Machine platform.

The New York Times looks at the growth of the Personal Genome Project.

In PNAS this week: 1918 flu virus analysis, single-cell transcriptome sequencing, and more.

NEW YORK (GenomeWeb) – Circulomics today announced the National Institutes of Health has awarded it a Phase I Small Business Innovation Research grant to develop its new Nanobind DNA/RNA extraction technology.

NEW YORK (GenomeWeb) – IBM today announced a collaboration with Coriell Life Sciences and CareKinesis to analyze and store genetic data from elderly patients in an effort to improve and better manage their medication regimens.

NEW YORK (GenomeWeb) – Luminex said this week that double-digit growth in sales of its xTAG Respiratory Viral and Gastrointestinal Pathogen Panels contributed to an increase in first quarter revenues.

NEW YORK (GenomeWeb) – CardioDx's 2013 revenues increased more than three-fold year over year, the company said in a regulatory document on Monday.

NEW YORK (GenomeWeb) — Microarray sales to agricultural and cancer researchers as well as reproductive health and consumer clients drove Illumina's chip revenues up 4 percent in the first quarter, the company said last week.